Treatment of mycosis fungoides using a 308-nm excimer laser: Two case studies

Dermatology Online Journal

Volumn 12, Issue 7, 2006, Pages

  Meisenheimer, John L ^a  

^a South Orlando Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; CHLORMETHINE; DIFLORASONE DIACETATE; PSORALEN; STEROID;

ADULT; AGED; ARTICLE; CASE REPORT; ELECTRON THERAPY; EXCIMER LASER; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN TISSUE; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PSORIASIS; PUVA; RADIATION DOSE; SKIN BIOPSY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO; BIOPSY; LOW LEVEL LASER THERAPY; MIDDLE AGED; PATHOLOGY; SKIN;

AGED; BIOPSY; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; MIDDLE AGED; MYCOSIS FUNGOIDES; SKIN;

EID: 33845638624     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Apisarnthanarax N, Talpur R, Duvic M. Treatment of cutaneous T cell lymphoma: current status and future directions. Am J Clin Dermatol. 2002;3(3):193-215.
2. Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early stage cutaneous T-cell lymphoma. Arch Dermatol. 1992 Jul;128(7):931-33.
3. Resnik KS, Vonderheid EC. Home UV phototherapy of early mycosis fungoides: long term follow-up observations in thirty one patients. J Am Acad Dermatol. 1993 Jul(1);29:73-7.
4. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311 nm) UVB therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol. 1999 Nov;135(11):1377-80.
5. Clark C, Dawe RS, Evans AT et al. Narrowband TL 01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol. 2000 Jun;136(6):748-752.
6. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol. 2002 Aug;47(2):191-7.
7. Diederen PV, van Weelden H, Sanders CJG, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol. 2003 Feb;48(2):215-219.
8. El-Mofty M, El-Darouty M, Salonas M, et al. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study. Photodermatol Photoimmunol Photomed. 2005 Dec;21(6):281-6.
9. Boztepe G, Sahin S, Ayhan M, Erkin G, Kilemen F. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol. 2005 Aug;53(2):242-6.
10. Ghodsi SZ, Hallaji Z, Balighi K, Safar F, Chams-Davatchi C. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol. 2005 Jul;30(4):376-8.
11. Nistico S, Costanzo A, Saraceno R, Chimenti S. Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol. 2004 Oct;151(4):877-9.
12. Passeron T, Zakaria W, Ostovari N, Perrin C, Larrouy JC, Lacour JP, Ortonne JP. Efficacy of the 308-nm excimer laser in the treatment of mycosis fungoides. Arch Dermatol. 2004 Oct;140(10):1291-3.
13. Mori M, Campolmi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. Monochromatic excimer light (308 nm) in patch-stage IA mycosis fungoides. J Am Acad Dermatol. 2004 Jun;50(6):943-5.
14. Upjohn E, Lane P, Foley p, Sinclair R, Magee J. Histological clearance of patch stage mycosis fungoides with the 308 nm excimer laser. 63rd Annual Meeting of the American Academy of Dermatology, New Orleans, LA, 2004. Poster #15.
15. U.S. Food and Drug Administration. Center for Devices and Radiological Health. 510K Approval #K992914. Issued January 27, 2000.
16. U.S. Food and Drug Administration. Center for Devices and Radiological Health. 510K Approval #K003705. Issued March 1, 2001.
17. Stern RS, Bolshakov S, Nataraj AJ, et al. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol. 2002 Aug;119(2):522-6.
18. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol. 2003 Aug; 121(2):252-8.